Related Experiment Video
Updated: Apr 13, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Sleep and glycemic control in type 1 diabetes
Mark Thomaz Ugliara Barone1, Daniela Wey2, Fabiola Schorr3
1Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, Brazil.
Archives of Endocrinology and Metabolism
|May 1, 2015
Summary
Type 1 diabetes mellitus (T1DM) is linked to altered sleep patterns, with poorer glycemic control correlating with worse sleep quality. This highlights the importance of sleep in managing T1DM.
Area of Science:
- Endocrinology
- Sleep Medicine
- Metabolic Disorders
Background:
- Type 1 diabetes mellitus (T1DM) management requires careful attention to various physiological factors.
- The interplay between sleep parameters and T1DM has been underexplored.
- Understanding this relationship is crucial for comprehensive diabetes care.
Purpose of the Study:
- To investigate the interaction between sleep parameters and T1DM.
- To determine how sleep characteristics influence glycemic control in individuals with T1DM.
Main Methods:
- Study included 18 T1DM subjects and 9 age/BMI-matched controls.
- Sleep was assessed using Epworth Sleepiness Scale, sleep diaries, actimetry, and polysomnography.
- Glycemic control was evaluated via A1C, home glucose monitoring, and continuous glucose monitoring (CGM).
Main Results:
- T1DM subjects exhibited greater sleep extension from weekdays to weekends compared to controls.
- Glycemic variability positively correlated with sleep latency in T1DM.
- A1C levels correlated with full awakening and arousal indices; mean glycemia negatively correlated with sleep quality in well-controlled T1DM.
Conclusions:
- A significant interaction exists between sleep parameters and T1DM, with glycemic control playing a key role.
- Further research is needed to elucidate the underlying mechanisms of this interaction.
- Sleep management may become an important consideration for regulating glycemic control in T1DM patients.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
2.3K
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
2.4K
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:16Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K